CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • October 25th, 2021 • Supernus Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledOctober 25th, 2021 Company Industry JurisdictionTHIS CONTINGENT VALUE RIGHTS AGREEMENT, dated as of [●], 2021 (this “Agreement”), is entered into by and between Supernus Pharmaceuticals, Inc., a Delaware corporation (“Parent”), and American Stock Transfer & Trust Company, LLC, a New York limited liability trust company (the “Rights Agent”).